COMPARISION OF THE SHORT-TERM EFFECTS OF CANDOXATRIL, AN ORALLY ACTIVE NEUTRAL ENDOPEPTIDASE INHIBITOR, AND FRUSEMIDE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE

NORTHRIDGE, D.B., NEWBY, D.E., ROONEY, E., NORRIE, J., & DARGIE, H.J.. (1999). COMPARISION OF THE SHORT-TERM EFFECTS OF CANDOXATRIL, AN ORALLY ACTIVE NEUTRAL ENDOPEPTIDASE INHIBITOR, AND FRUSEMIDE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. AMERICAN HEART JOURNAL, 138(-), 1149-1157. SID. https://sid.ir/paper/540292/en

NORTHRIDGE D.B., NEWBY D.E., ROONEY E., NORRIE J., DARGIE H.J.. COMPARISION OF THE SHORT-TERM EFFECTS OF CANDOXATRIL, AN ORALLY ACTIVE NEUTRAL ENDOPEPTIDASE INHIBITOR, AND FRUSEMIDE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. AMERICAN HEART JOURNAL[Internet]. 1999;138(-):1149-1157. Available from: https://sid.ir/paper/540292/en

D.B. NORTHRIDGE, D.E. NEWBY, E. ROONEY, J. NORRIE, and H.J. DARGIE, “COMPARISION OF THE SHORT-TERM EFFECTS OF CANDOXATRIL, AN ORALLY ACTIVE NEUTRAL ENDOPEPTIDASE INHIBITOR, AND FRUSEMIDE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE,” AMERICAN HEART JOURNAL, vol. 138, no. -, pp. 1149–1157, 1999, [Online]. Available: https://sid.ir/paper/540292/en